MedTrace Logo

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

NCT00477100 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2026-04-15

No results posted yet for this study

Summary

This trial studies the biospecimen and medical data collection in creating a research tissue registry in patients with inflammatory or invasive breast cancer. Collecting medical data and storing samples of blood, tissue, and stool from patients with inflammatory breast cancer to study in the laboratory may help doctors find better ways to treat and study inflammatory breast cancer in the future.

Conditions

  • Inflammatory Breast Carcinoma
  • Invasive Breast Carcinoma
  • Second Primary Malignant Neoplasm

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of blood, tissue, and stool

OTHER

Interview

Participate in interview

OTHER

Medical Chart Review

Undergo collection of medical data

OTHER

Questionnaire Administration

Ancillary Studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Texas Appropriation for Rare and Aggressive diseases

    collaborator UNKNOWN

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • VIcente Valero, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-17
Primary Completion
2030-04-30
Completion
2030-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00477100 on ClinicalTrials.gov